Workflow
阳光乳业(001318) - 2024 Q1 - 季度财报

Financial Performance - The company's operating revenue for Q1 2024 was ¥108,881,781.06, a decrease of 6.36% compared to ¥116,279,377.63 in the same period last year[6]. - The net profit attributable to shareholders for Q1 2024 was ¥21,504,922.08, down 1.96% from ¥21,935,327.82 in Q1 2023[6]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was ¥22,294,005.72, an increase of 0.96% from ¥22,082,983.04 in the previous year[6]. - The total comprehensive income attributable to the parent company's owners was 21,504,922.08, compared to 21,935,327.82 in the previous period, reflecting a decrease of approximately 1.96%[29]. - The net profit for the period was 19,689,324.27, down from 21,111,006.39, indicating a decline of about 6.73%[29]. - The total profit for the period was 20,991,294.31, down from 22,618,059.05, representing a decline of approximately 7.2%[29]. Cash Flow - The net cash flow from operating activities for Q1 2024 was -¥5,859,400.09, a significant decrease of 175.94% compared to ¥7,716,054.03 in Q1 2023[6]. - Cash inflows from operating activities totaled 122,124,296.98, an increase from 118,186,822.27 in the prior period[30]. - Cash outflows from operating activities amounted to 127,983,697.07, compared to 110,470,768.24 previously, resulting in a net cash flow from operating activities of -5,859,400.09[30]. - The net cash flow from investing activities was -4,680,728.28, an improvement from -5,019,066.10 in the previous period[32]. - The cash and cash equivalents at the end of the period were 477,347,078.17, down from 487,887,206.54 at the beginning of the period[32]. Assets and Liabilities - The total assets at the end of Q1 2024 were ¥1,426,600,629.07, a slight decrease of 0.06% from ¥1,427,404,152.93 at the end of the previous year[6]. - The total liabilities decreased to RMB 61,435,512.83 from RMB 81,928,360.96, indicating a reduction of 25.1%[23]. - The total current assets at the end of the period were RMB 1,027,947,798.83, slightly up from RMB 1,020,122,359.30 at the beginning of the period[18]. - The cash and cash equivalents at the end of the period were RMB 477,347,078.17, a slight decrease from RMB 487,887,206.54 at the beginning of the period[18]. Shareholder Information - The equity attributable to shareholders at the end of Q1 2024 was ¥1,356,211,507.85, an increase of 1.50% from ¥1,336,112,706.50 at the end of the previous year[6]. - The controlling shareholder, Jiangxi Sunshine Dairy Group, increased its stake by 776,800 shares, totaling RMB 8,120,518.44, with plans to invest an additional RMB 10 million to 20 million within six months[17]. - The company plans to continue its stock buyback strategy based on the reasonable assessment of the stock's value[17]. Operational Metrics - The basic and diluted earnings per share for Q1 2024 were both ¥0.0761, a decrease of 1.93% from ¥0.0776 in the same period last year[6]. - The weighted average return on equity for Q1 2024 was 1.60%, down from 1.72% in the previous year[6]. - The total operating costs amounted to RMB 87,235,482.44, down from RMB 94,077,429.82, reflecting a reduction of 7.8%[24]. - The gross profit margin improved to 19.3%, compared to 18.9% in the same period last year[24]. - Research and development expenses increased significantly to RMB 5,096,005.31, up 71.0% from RMB 2,980,766.45 in the previous year[24]. Other Income - The company received government subsidies amounting to ¥687,852.93 during the quarter, which positively impacted its financial performance[6]. - The company reported a decrease in other income to 687,852.93 from 461,183.06 in the previous period[28]. - The company reported a loss of ¥1,412,385.70 from the disposal of non-current assets, specifically related to biological assets[6]. Sales Performance - The company experienced a significant increase in sales revenue, with cash received from sales reaching 119,958,994.41, compared to 116,374,569.85 in the previous period[30].